Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes

Cancer Cell(2024)10.1016/j.ccell.2024.01.001Source: DataRank Database

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes is a research paper published in Cancer Cell (2024). On theSindex it has a DataRank of 0.718. It has been cited 119 times.

N/A

0.718DataRank · unranked

Scored on demand from live citation data

Open Access119 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 20.81)OA: hybridTopics (23)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.718

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (42)

Carl M. Gay ORCID,Marcos R. Estecio ORCID,Hai T. Tran ORCID,Benjamin B. Morris ORCID,Bingnan Zhang ORCID

Live enrichment

PubMed:38278149 OpenAlex:https://openalex.org/W4391219445

UKRI Medical Research Council

Grant: CC2008

Horizon 2020

Grant: 829218

Cancer Prevention and Research Institute of Texas

Grant: RR210006

Cancer Prevention and Research Institute of Texas

Grant: RP210159

Cancer Prevention and Research Institute of Texas

Grant: 170002

Cancer Prevention and Research Institute of Texas

Grant: 120348

NIH

Grant: CA233259

NIH

Grant: CA224276

NIH

Grant: CA217450

NCI

Grant: R50CA243698

NCI

Grant: U24CA213274

NCI

Grant: SCLC U01CA213273

NCI

Grant: P50CA070907

NCI

Grant: 1R50CA265307

NCI

Grant: SCLC U01CA256780

NCI

Grant: R01CA207295

NCI

Grant: CA016672

FWCI

20.81

Citation Percentile

1.0%

Citation Trend

2019

2022

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ccell.2024.01.001

publisherhttps://doi.org/10.1016/j.ccell.2024.01.001

publisherhttps://api.elsevier.com/content/article/PII:S1535610824000060?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610824000060?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38278149

Fields of Study

Lung Cancer Research StudiesEpigenetics and DNA MethylationNeuroendocrine Tumor Research Advances

MeSH Terms

Cell-Free Nucleic AcidsHumansLung NeoplasmsBiomarkers, TumorDNA MethylationEpigenesis, GeneticSmall Cell Lung Carcinoma

Keywords

SubtypingDNA methylationEpigeneticsBiologyLung cancerMalignancyCancer researchMethylationOncologyGeneMedicineGene expressionGenetics

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (10)

Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression

N/A

0.474DataRank · unranked

Cancer Cell(2025)

co-citedsame journal

10.1016/j.ccell.2025.06.004

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

N/A

1.0DataRank · unranked

Cancer Cell(2021)

co-citedsame journal

10.1016/j.ccell.2020.12.014

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

N/A

0.788DataRank · unranked

Cancer Cell(2024)

co-citedsame journal

10.1016/j.ccell.2023.12.013

Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

N/A

0.505DataRank · unranked

Cancer Cell(2025)

co-citedsame journal

10.1016/j.ccell.2025.04.003

Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer

N/A

0.888DataRank · unranked

Nature Cancer(2022)

co-cited

10.1038/s43018-022-00416-8

Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution

N/A

0.879DataRank · unranked

Cell(2022)

co-cited

10.1016/j.cell.2022.04.015

Machine Learning for Lung Cancer Diagnosis, Treatment, and Prognosis

Genomics Proteomics & Bioinformatics(2022)

co-cited

10.1016/j.gpb.2022.11.003

Multiplex Digital Methylation‐Specific PCR for Noninvasive Screening of Lung Cancer

Advanced Science(2023)

co-cited

10.1002/advs.202206518

Assessing GPT-4 for cell type annotation in single-cell RNA-seq analysis

N/A

0.820DataRank · unranked

Nature Methods(2024)

co-cited

10.1038/s41592-024-02235-4

An atlas of epithelial cell states and plasticity in lung adenocarcinoma

Nature(2024)

co-cited

10.1038/s41586-024-07113-9